Skip to Main Content

Technology Development for Noninvasive Prenatal Genetic Diagnosis Using Maternal Peripheral Blood

  • Study HIC#:2000030949
  • Last Updated:05/26/2024

The purpose of this study is to develop a risk-free noninvasive prenatal diagnosis procedure for genetic conditions in the developing fetus by studying fetal cells in maternal blood. 

  • Age18 years and older
  • GenderFemale only

Contact Us

For more information about this study, including how to volunteer, contact:

Audrey Merriam

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call +18779788343 for more information.

Trial Purpose and Description

The purpose of this study is to develop a risk-free noninvasive prenatal diagnosis procedure for genetic conditions in the developing fetus by studying fetal cells in maternal blood. 

Eligibility Criteria

Eligibility Criteria:

  • >/= 18yo, singleton or twin gestation
  • planning to undergo CVS or amniocentesis

Principal Investigator

For more information about this study, including how to volunteer, contact: